Abstract

Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy

Author(s): Fichter Brian, Heintzelman Tom, Hurst Sawan, Fitzsimmons Dorothy, Mailloux Christina

Issue: Nov/Dec 2013 - Volume 17, Number 6

Page(s): 452-457

Download in electronic PDF format for $75
  • Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 1
  • Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 2
  • Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 3
  • Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 4
  • Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 5
  • Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 6

Abstract

Pharmacists must consider all factors when dosing medication for a patient. Until recently, however, one key piece to this puzzle was missing—genetics. This invisible piece of the puzzle can now be utilized with pharmacogenetic testing. By using pharmacogenetic testing, the compounding pharmacist will be able to better predict disease risk as well as the pharmacodynamic and pharmacokinetic actions of the prescriptions their patients are taking. Pharmacogenetics is poised to become the standard of care that not only physicians are embracing, but pharmacists can utilize to better personalize their patient’s needs.

Related Keywords

  • pharmacogenetics
  • genetics
  • genetic testing
  • personalize
  • personalization
  • metabolic pathways
  • response to therapy
  • breast cancer risk prediction
  • hormone replacement therapy
  • HRT
  • cytochrome P450
  • warfarin
  • gene mutations
  • single nucleotide polymorphisms

Related Categories

  • HRT
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE
  • PATIENT ASSESSMENT

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2013
Pg. 452-457
Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy
Author(s): Fichter Brian, Heintzelman Tom, Hurst Sawan, Fitzsimmons Dorothy, Mailloux Christina
Sep/Oct 2009
Pg. 392-399
Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing
Author(s): Kells John, Dollbaum Charles M
Jul/Aug 2011
Pg. 290-300
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review
Author(s): Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
Jul/Aug 2003
Pg. 250-256
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Author(s): Gillson George R, Zava David T
Jan/Feb 2015
Pg. 6-12
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2009
Pg. 280-288
Saliva Tests, Part 1: Clinical Use, Elements of Testing, and Guidelines for Posttreatment Interpretation
Author(s): Kells John, Dollbaum Charles M
Jan/Feb 2001
Pg. 52-54
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Author(s): Ford Gina, Garcia Lea
Sep/Oct 2016
Pg. 359-364
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Author(s): Deleruyelle Laura J
Nov/Dec 2016
Pg. 447-454
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Author(s): Deleruyelle Laura J
Jul/Aug 2013
Pg. 307-311
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
Author(s): McElhiney Linda F
Jan/Feb 2002
Pg. 50-54
Bioidentical Hormone Replacement Therapy, Part 2, A Review of
Author(s): Wepfer Scott T
Mar/Apr 2002
Pg. 142-146
Bioidentical Hormone Replacement Therapy, Part 3, A Review of
Author(s): Wepfer Scott T
May/Jun 2017
Pg. 193-203
Microbiologic Testing for 503A Sterile-Compounding Pharmacies
Author(s): Mixon William, Roth Abby
May/Jun 2018
Pg. 190-195
Establishing a Rationale for Compounding Hormone Replacement Therapy
Author(s): Biundo Bruce
Jan/Feb 2024
Pg. 22-27
Establishing a Rationale for Compounding Hormone Replacement Therapy
Author(s): Biundo Bruce
Jul/Aug 2009
Pg. 314-317
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding
Author(s): Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
Mar/Apr 2008
Pg. 122-127
Hormone Therapy: It's Time for a Second Opinion
Author(s): Collins Joseph J, Ahlgrimm Maria
Jul/Aug 2014
Pg. 305-310
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2
Author(s): Vu Nicole, Lou Jessica R, Kupiec Thomas C
Nov/Dec 2004
Pg. 412
Book Review: HRT: The Answers. A Concise Guide for Solving the Hormone Replacement Therapy Puzzle
Author(s): Reed-Kane Dana
May/Jun 2006
Pg. 175-183
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States
Author(s): Stephenson Kenna, Jones William, Stephenson Douglas M M